|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-10-22
|
|
pubmed:abstractText |
Patients (pts) with primary metastatic Ewing tumours (ET) have a poor prognosis for event free survival (EFS) compared to pts with localised disease. Following relapse the prognosis is extremely poor. Therefore these primary metastatic and relapsed pts were piloted for high dose therapy (HDT) for the last years.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8630
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
211
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
284-90
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10472563-Adolescent,
pubmed-meshheading:10472563-Adult,
pubmed-meshheading:10472563-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10472563-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10472563-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10472563-Bone Marrow Transplantation,
pubmed-meshheading:10472563-Bone Neoplasms,
pubmed-meshheading:10472563-Child,
pubmed-meshheading:10472563-Combined Modality Therapy,
pubmed-meshheading:10472563-Dose-Response Relationship, Drug,
pubmed-meshheading:10472563-Drug Administration Schedule,
pubmed-meshheading:10472563-Etoposide,
pubmed-meshheading:10472563-Female,
pubmed-meshheading:10472563-Germany,
pubmed-meshheading:10472563-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10472563-Humans,
pubmed-meshheading:10472563-Male,
pubmed-meshheading:10472563-Melphalan,
pubmed-meshheading:10472563-Sarcoma, Ewing,
pubmed-meshheading:10472563-Survival Analysis,
pubmed-meshheading:10472563-Treatment Outcome
|
|
pubmed:articleTitle |
[High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
|
|
pubmed:affiliation |
Klinik für Pädiatrische Hämatologie und Onkologie, Westfälische Wilhelms-Universität, Münster. eicess@uni-muenster.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Multicenter Study
|
